Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Reviews/Consensus Reports/ADA Statements

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  1. Silvio E. Inzucchi, MD1,
  2. Richard M. Bergenstal, MD2,
  3. John B. Buse, MD, PHD3,
  4. Michaela Diamant, MD, PHD4,
  5. Ele Ferrannini, MD5,
  6. Michael Nauck, MD6,
  7. Anne L. Peters, MD7,
  8. Apostolos Tsapas, MD, PHD8,
  9. Richard Wender, MD9 and
  10. David R. Matthews, MD, DPHIL10,11,12
  1. From the 1Section of Endocrinology, Yale University School of Medicine and Yale-New Haven Hospital, New Haven, Connecticut; the
  2. 2International Diabetes Center at Park Nicollet, Minneapolis, Minnesota; the
  3. 3Division of Endocrinology, University of North Carolina School of Medicine, Chapel Hill, North Carolina; the
  4. 4Diabetes Center/Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands; the
  5. 5Department of Medicine, University of Pisa School of Medicine, Pisa, Italy;
  6. 6Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany; the
  7. 7Division of Endocrinology, Keck School of Medicine, University of Southern California, Los Angeles, California; the
  8. 8Second Medical Department, Aristotle University Thessaloniki, Thessaloniki, Greece; the
  9. 9Department of Family and Community Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania; the
  10. 10Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Headington, Oxford, U.K.; the
  11. 11National Institute for Health Research (NIHR), Oxford Biomedical Research Centre, Oxford, U.K.; and the
  12. 12Harris Manchester College, University of Oxford, Oxford, U.K
  1. Corresponding author: Silvio E. Inzucchi, silvio.inzucchi{at}yale.edu.
  1. S.E. Inzucchi and D.R. Matthews were co-chairs for the Position Statement Writing Group. R.M. Bergenstal, J.B. Buse, A.L. Peters, and R. Wender were the Writing Group for the ADA. M. Diamant, E. Ferrannini, M. Nauck, and A. Tsapas were the Writing Group for the EASD.

Diabetes Care 2012 Jun; 35(6): 1364-1379. https://doi.org/10.2337/dc12-0413
PreviousNext
  • Article
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 35 no. 6 1364-1379
DOI 
https://doi.org/10.2337/dc12-0413
PubMed 
22517736

Published By 
American Diabetes Association
Print ISSN 
0149-5992
Online ISSN 
1935-5548
History 
  • Published in print May 22, 2012.
  • Published online ahead of print April 19, 2012.

Article Versions

  • Previous version (April 19, 2012 - 05:50).
  • Previous version (April 19, 2012 - 12:06).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

Author Information

  1. Silvio E. Inzucchi, MD1,
  2. Richard M. Bergenstal, MD2,
  3. John B. Buse, MD, PHD3,
  4. Michaela Diamant, MD, PHD4,
  5. Ele Ferrannini, MD5,
  6. Michael Nauck, MD6,
  7. Anne L. Peters, MD7,
  8. Apostolos Tsapas, MD, PHD8,
  9. Richard Wender, MD9 and
  10. David R. Matthews, MD, DPHIL10,11,12
  1. From the 1Section of Endocrinology, Yale University School of Medicine and Yale-New Haven Hospital, New Haven, Connecticut; the
  2. 2International Diabetes Center at Park Nicollet, Minneapolis, Minnesota; the
  3. 3Division of Endocrinology, University of North Carolina School of Medicine, Chapel Hill, North Carolina; the
  4. 4Diabetes Center/Department of Internal Medicine, VU University Medical Center, Amsterdam, the Netherlands; the
  5. 5Department of Medicine, University of Pisa School of Medicine, Pisa, Italy;
  6. 6Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany; the
  7. 7Division of Endocrinology, Keck School of Medicine, University of Southern California, Los Angeles, California; the
  8. 8Second Medical Department, Aristotle University Thessaloniki, Thessaloniki, Greece; the
  9. 9Department of Family and Community Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania; the
  10. 10Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Headington, Oxford, U.K.; the
  11. 11National Institute for Health Research (NIHR), Oxford Biomedical Research Centre, Oxford, U.K.; and the
  12. 12Harris Manchester College, University of Oxford, Oxford, U.K
  1. Corresponding author: Silvio E. Inzucchi, silvio.inzucchi{at}yale.edu.
  1. S.E. Inzucchi and D.R. Matthews were co-chairs for the Position Statement Writing Group. R.M. Bergenstal, J.B. Buse, A.L. Peters, and R. Wender were the Writing Group for the ADA. M. Diamant, E. Ferrannini, M. Nauck, and A. Tsapas were the Writing Group for the EASD.

View Abstract

Statistics from Altmetric.com

Article usage

Article usage: April 2012 to March 2021

Rendering graph...
AbstractFullPdf
Apr 2012027535306
May 2012101095523454
Jun 20121783235910219
Jul 2012128523928277
Aug 2012122519137459
Sep 2012123221078392
Oct 20121245901011814
Nov 201290327967687
Dec 201271419225161
Jan 20131098318313493
Feb 2013109534229789
Mar 2013036119217
Apr 2013040108693
May 20130367610072
Jun 201389230086328
Jul 2013159631836356
Aug 2013141629925997
Sep 2013194037376661
Oct 20132553441226768
Nov 20131740475923324
Dec 2013122726846844
Jan 2014146734258282
Feb 2014132432966309
Mar 2014144743157823
Apr 2014131143176335
May 2014113140795123
Jun 201490735534533
Jul 201484834845113
Aug 2014107833885188
Sep 2014109141675849
Oct 2014126952845307
Nov 2014119946284245
Dec 2014103544873370
Jan 2015139350066578
Feb 2015146643726073
Mar 2015162948723937
Apr 2015147136842978
May 2015111433212635
Jun 2015100331822550
Jul 201593229092438
Aug 2015114733752334
Sep 2015138132152447
Oct 2015150437512522
Nov 2015146936942362
Dec 2015123535231793
Jan 2016124437372286
Feb 2016145639682380
Mar 2016172346162729
Apr 2016173941572476
May 2016105740292674
Jun 201672928702682
Jul 201663127173789
Aug 201685429412663
Sep 201696632453340
Oct 2016107532002549
Nov 201699932652900
Dec 201663628701839
Jan 201760931761545
Feb 201769133271500
Mar 2017104035991854
Apr 201792133211345
May 201772328421348
Jun 201741923911053
Jul 2017522501148
Aug 20171523901035
Sep 2017829671187
Oct 2017729171167
Nov 2017229991125
Dec 201742071836
Jan 201891860915
Feb 2018191962970
Mar 20182625801040
Apr 20182635261045
May 20181263344826
Jun 2018353343685
Jul 2018473766800
Aug 2018343474848
Sep 2018243136734
Oct 2018253838867
Nov 2018112701706
Dec 201872694594
Jan 201932507581
Feb 20191652127641
Mar 20194191789903
Apr 20194161638822
May 20192971872653
Jun 20192051346574
Jul 2019331399476
Aug 201981610442
Sep 201932786428
Oct 201951425428
Nov 201921595488
Dec 201951074354
Jan 202011220328
Feb 202041198385
Mar 202041454427
Apr 202011331308
May 202081366388
Jun 202021218450
Jul 202061259479
Aug 202051018231
Sep 202041252642
Oct 202041348363
Nov 202061343292
Dec 202081124252
Jan 202121249384
Feb 202161095250
Mar 2021010437

PreviousNext
Back to top
Diabetes Care: 35 (6)

In this Issue

June 2012, 35(6)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L. Peters, Apostolos Tsapas, Richard Wender, David R. Matthews
Diabetes Care Jun 2012, 35 (6) 1364-1379; DOI: 10.2337/dc12-0413

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L. Peters, Apostolos Tsapas, Richard Wender, David R. Matthews
Diabetes Care Jun 2012, 35 (6) 1364-1379; DOI: 10.2337/dc12-0413
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • PATIENT-CENTERED APPROACH
    • BACKGROUND
    • ANTIHYPERGLYCEMIC THERAPY
    • OTHER CONSIDERATIONS
    • FUTURE DIRECTIONS/RESEARCH NEEDS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Suppl Material
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Reviews/Consensus Reports/ADA Statements

  • Changing Physical Activity Behavior in Type 2 Diabetes
  • Immune Response of Hepatitis B Vaccine Among Persons With Diabetes
  • Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes
Show more Reviews/Consensus Reports/ADA Statements

Position Statement

  • Changing Physical Activity Behavior in Type 2 Diabetes
  • Immune Response of Hepatitis B Vaccine Among Persons With Diabetes
  • Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes
Show more Position Statement

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.